Investing.com - Edwards Lifesciences (NYSE:EW) reported first quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $0.6 on revenue of $1.34B. Analysts polled by Investing.com forecast EPS of $0.5708 on revenue of $1.31B. .
Edwards Lifesciences shares lost 4.27% to trade at $111.31 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 10.25%, outperforming the S&P 500 which is down 12.4% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On April 19, J&J reported first quarter EPS of $2.67 on revenue of $23.43B, compared to forecasts of EPS of $2.59 on revenue of $23.62B.
UnitedHealth earnings beat analyst's expectations on April 14, with first quarter EPS of $5.49 on revenue of $80.15B. Investing.com analysts expected EPS of $5.36 on revenue of $78.73B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar